ARCHIVES

NCI Launches ALCHEMIST

This article is from The Cancer Letter archive.

Vol. 40 No. 33 | September 5, 2014

Download PDF Visit The Full Archive

Related Articles

Regorafenib Trial Meets Primary Endpoint; Overall Survival Improved by 29 Percent

January 27, 2012

Professional Societes; ASCO’s Strength Is In Its Diversify, Lichtor Says

May 21, 1999

Hopkins Begins Review Of All Studies After OHRP Lifts Research Suspension.

July 27, 2001

Abstracts Of Papers Presented By Breast Cancer Task Force

September 17, 1976

Martha Fewell, Assistant To NCI Directors, To Retire

May 3, 2002

In Brief: Thomas Davis, Stanford Oncologist, Dead At 49; DeVita To Visit, NCI; Hunter Named WHI Liaison

September 4, 1992